4.5 Article

Stromal FAP is an independent poor prognosis marker in non-small cell lung adenocarcinoma and associated with p53 mutation

Related references

Note: Only part of the references are listed.
Review Biochemistry & Molecular Biology

Molecular recognition of fibroblast activation protein for diagnostic and therapeutic applications

Adela Simkova et al.

BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2020)

Article Oncology

A framework for advancing our understanding of cancer-associated fibroblasts

Erik Sahai et al.

NATURE REVIEWS CANCER (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer

Clemens Kratochwil et al.

JOURNAL OF NUCLEAR MEDICINE (2019)

Article Multidisciplinary Sciences

Sex and survival in non-small cell lung cancer: A nationwide cohort study

Cecilia Radkiewicz et al.

PLOS ONE (2019)

Article Multidisciplinary Sciences

Differential prognostic impact of platelet-derived growth factor receptor expression in NSCLC

Thomas Karsten Kilvaer et al.

SCIENTIFIC REPORTS (2019)

Article Oncology

Sex differences in cancer risk and survival: A Swedish cohort study

Cecilia Radkiewicz et al.

EUROPEAN JOURNAL OF CANCER (2017)

Article Multidisciplinary Sciences

Stromal Versican Regulates Tumor Growth by Promoting Angiogenesis

Keiichi Asano et al.

SCIENTIFIC REPORTS (2017)

Article Oncology

Fibulin-5 Blocks Microenvironmental ROS in Pancreatic Cancer

Miao Wang et al.

CANCER RESEARCH (2015)

Review Oncology

PDGF receptors in tumor biology: prognostic and predictive potential

Janna Paulsson et al.

FUTURE ONCOLOGY (2014)

Review Oncology

Prognostic relevance of cancer-associated fibroblasts in human cancer

Janna Paulsson et al.

SEMINARS IN CANCER BIOLOGY (2014)

Article Oncology

CD99 is a novel prognostic stromal marker in non-small cell lung cancer

Karolina Edlund et al.

INTERNATIONAL JOURNAL OF CANCER (2012)